The natural compound sulforaphene, as a novel anticancer reagent, targeting PI3K-AKT signaling pathway in lung cancer.
about
A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer.The quinone-based derivative, HMNQ induces apoptotic and autophagic cell death by modulating reactive oxygen species in cancer cells.Phytochemicals and PI3K Inhibitors in Cancer—An Insight.Phytochemicals and PI3K Inhibitors in Cancer-An Insight.Adaptively capturing the heterogeneity of expression for cancer biomarker identification
P2860
The natural compound sulforaphene, as a novel anticancer reagent, targeting PI3K-AKT signaling pathway in lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The natural compound sulforaph ...... naling pathway in lung cancer.
@en
The natural compound sulforaph ...... naling pathway in lung cancer.
@nl
type
label
The natural compound sulforaph ...... naling pathway in lung cancer.
@en
The natural compound sulforaph ...... naling pathway in lung cancer.
@nl
prefLabel
The natural compound sulforaph ...... naling pathway in lung cancer.
@en
The natural compound sulforaph ...... naling pathway in lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
The natural compound sulforaph ...... naling pathway in lung cancer.
@en
P2093
Haiyong Wang
Pengqun Kuang
Qipeng Yuan
Weilin Liu
P2860
P304
76656-76666
P356
10.18632/ONCOTARGET.12307
P407
P50
P577
2016-09-28T00:00:00Z